Cassava Sciences Inc (SAVA)
26.30
-0.61
(-2.27%)
USD |
NASDAQ |
Nov 18, 09:52
Cassava Sciences Price: 26.30 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 15, 2024 | 26.46 | 28.99 | 25.46 | 26.91 | 2.819M |
| Nov 14, 2024 | 25.59 | 26.66 | 25.40 | 26.14 | 1.233M |
| Nov 13, 2024 | 26.31 | 27.00 | 25.00 | 25.18 | 1.131M |
| Nov 12, 2024 | 26.89 | 27.20 | 25.92 | 26.38 | 905809.0 |
| Nov 11, 2024 | 27.76 | 28.18 | 26.77 | 27.06 | 1.191M |
| Nov 08, 2024 | 25.00 | 27.98 | 24.75 | 26.95 | 2.036M |
| Nov 07, 2024 | 26.42 | 27.16 | 24.64 | 25.34 | 1.653M |
| Nov 06, 2024 | 24.64 | 27.03 | 23.90 | 26.57 | 1.949M |
| Nov 05, 2024 | 25.54 | 25.70 | 23.46 | 23.93 | 1.909M |
| Nov 04, 2024 | 26.41 | 26.70 | 25.45 | 25.84 | 1.008M |
| Nov 01, 2024 | 25.81 | 26.25 | 25.55 | 26.21 | 1.384M |
| Oct 31, 2024 | 25.80 | 26.19 | 24.80 | 25.80 | 1.437M |
| Oct 30, 2024 | 26.30 | 26.62 | 25.86 | 26.00 | 1.178M |
| Oct 29, 2024 | 26.70 | 26.82 | 26.15 | 26.52 | 784560.0 |
| Oct 28, 2024 | 26.99 | 27.56 | 26.46 | 26.73 | 925809.0 |
| Oct 25, 2024 | 27.25 | 27.75 | 26.51 | 26.55 | 1.207M |
| Oct 24, 2024 | 28.06 | 28.29 | 26.95 | 27.29 | 965239.0 |
| Oct 23, 2024 | 28.30 | 28.83 | 26.88 | 27.99 | 1.191M |
| Oct 22, 2024 | 28.82 | 28.97 | 28.16 | 28.43 | 825120.0 |
| Oct 21, 2024 | 29.00 | 29.60 | 28.32 | 28.88 | 881311.0 |
| Oct 18, 2024 | 29.64 | 30.11 | 28.73 | 29.00 | 1.347M |
| Oct 17, 2024 | 29.75 | 30.39 | 28.86 | 29.58 | 1.138M |
| Oct 16, 2024 | 28.40 | 30.07 | 28.26 | 29.63 | 1.536M |
| Oct 15, 2024 | 27.12 | 28.38 | 27.10 | 28.26 | 1.252M |
| Oct 14, 2024 | 26.09 | 28.28 | 25.41 | 27.50 | 2.064M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.239
Minimum
Nov 18 2019
135.30
Maximum
Jul 28 2021
27.97
Average
24.01
Median
Mar 30 2023
Price Benchmarks
| Bristol-Myers Squibb Co | 56.63 |
| Seelos Therapeutics Inc | 0.44 |
| EyePoint Pharmaceuticals Inc | 8.89 |
| PTC Therapeutics Inc | 39.13 |
| Adverum Biotechnologies Inc | 6.95 |
Price Related Metrics
| PS Ratio | 28.86 |
| Price to Book Value | 7.593 |
| Earnings Yield | -5.25% |
| Market Cap | 1.265B |
| Operating PE Ratio | 37.83 |
| Normalized PE Ratio | 5.525 |